Objective
To investigate the effect of Chinese medicinal with actions of Invigorating blood circulation, softing scleroma and firming collaterals prescription on coronary microvascular thrombosis and endothelial injury factor in rats.
Methods
60 Wistar rats were randomLy divided into: Sham operation group, Model group, Nicorandil group and Chinese medicine group.The sham operation group was used as the control group.The model was established by injecting sodium laurate into the left ventricle of rats to establish rat models of coronary microvascular hrombosis and endothelial function injury.The drug group was given Nicorandil 1.5 mg·(kg·d)-1, Traditional Chinese Medicine prescription 15 g·(kg·d)-1, Sham operation group and Model group were given the same amount of distilled water. After the 28th day,treatment was selected as the observation point to observe the myocardial pathological changes and coronary microvascular thrombosis occlusion, and to detect the serum levels of Prostaglandin Ⅰ2(PGI2) and Thromboxane A2(TXA2).
Results
Compared with the sham operation group, the left ventricular injection of sodium laurate in the model group led to coronary microvascular thrombosis and myocardial tissue pathological damage; After 28 days of medication, compared with the model group, the traditional Chinese medicine group could reduce microvascular embolism, improve myocardial pathological damage, increase serum prostaglandin Ⅰ2(PGI2) and reduce thromboxane A2(TXA2); Compared with the nicorandil group, there was no significant difference in the improvement of microvascular thrombosis and the reduction of endothelial injury factor in the traditional Chinese medicine group.
Conclusion
Sodium laurate can cause coronary microvascular thrombosis and endothelial injury in rats.For 28 days, the traditional Chinese medicine group could reduce the pathological state of coronary microvascular embolization and improve the endothelial function of microvascular lesions.Compared with Nicordil, there was no obvious advantage in Chinese medicine group.